Description: Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Home Page: www.nyxoah.com
Rue Edouard Belin 12
Mont-Saint-Guibert,
1435
Belgium
Phone:
32 10 22 23 55
Officers
| Name | Title |
|---|---|
| Mr. Robert Taub MBA | Co-Founder & Chairman |
| Mr. Olivier Taelman | CEO & Executive Director |
| Mr. Loic Moreau | President of International |
| Mr. John Landry | Chief Financial Officer |
| Mr. Bruno Onkelinx | Chief Technology Officer |
| Mikaela Kirkwood | Corporate Communication & Investor Relations Manager |
| Ms. An Moonen | General Counsel |
| Ms. Maggie McGowan | Chief HR Officer |
| Mr. Remi Renard | Chief of Staff |
| Mr. Jeyakumar Subbaroyan | Chief Clinical Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4878 |
| Price-to-Sales TTM: | 54.3513 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 146 |